Cargando…
Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
BACKGROUND: The majority of patients with newly diagnosed metastatic prostate cancer (PC) initially respond to androgen deprivation therapy (ADT) and are classified as metastatic castration-sensitive PC (mCSPC). Following months to years of ADT, the disease tends to become resistant to ADT. Recent r...
Autores principales: | Isaksson, Jenny, Green, Henrik, Papantoniou, Dimitrios, Pettersson, Linn, Anden, Mats, Rosell, Johan, Åvall-Lundqvist, Elisabeth, Elander, Nils Oskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641012/ https://www.ncbi.nlm.nih.gov/pubmed/34909396 http://dx.doi.org/10.5306/wjco.v12.i11.1009 |
Ejemplares similares
-
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
por: Asowed, Mustafa, et al.
Publicado: (2023) -
First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study
por: Falco, Agustín, et al.
Publicado: (2022) -
Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil
por: Suzuki, Kosuke, et al.
Publicado: (2021) -
Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer
por: Gränsmark, Emma, et al.
Publicado: (2020) -
Cardiovascular disease: Risk factors and applicability of a risk model in a Greek cohort of renal transplant recipients
por: Anastasopoulos, Nikolaos-Andreas, et al.
Publicado: (2017)